 |
|
 |
|
|
 |
Professor of Urology
Chief of Urology - Olive View-UCLA Medical Center
Chief of Urologic Oncology - Wadsworth VA Medical Center
|
 |
|
| Undergraduate: |
B.S., University of Wisconsin, Madison, WIsconsin |
| Medical School: |
M.D., Washington University School of Medicine, St. Louis, Missouri |
| Residency: |
University of California, Los Angeles |
Board
Certifications
& Fellowships: |
Diplomate, American Board of Urology - 1995
|
Urologic oncology, prostate cancer and general urology
|
-Fellow, American College of Surgeons - 1996 - Present
-American Urological Association, Western Section
-American Urological Association
|
| Academic
& Medical Staff Appointments |
 |
 |
 |
Professor of Urology - 2005 to present
Associate Clinical Professor of Urology - 2000 to 2005
Assistant Clinical Professor - 1993 - 1999
Department Representative, Department of Surgery Quality Improvement Committee, Olive View-UCLA Medical Center
Member, Jonsson Comprehensive Cancer Center, UCLA
Jonsson Comprehensive Cancer Center Quality Assurance Committee |
| Research
& Clinical Interests |
 |
 |
 |
Clinical and basic science research in nutrition and lifestyle factors for prostate
cancer including dietary fat, omega-3 fatty acids, lycopene, green tea, pomegranate, and exercise. Prostate cancer prevention. Surgical treatment of localized prostate cancer and treatment of advanced prostate cancer. |
1991 First Place Resident Essay Contest, Western Section-AUA: The role of nitric
oxide in mediating human penile erection.
1992 First Place Resident Essay Contest, Western Section-AUA, Hawaii: The role of
nitric oxide and cGMP in mediating pelvic nerve stimulation induced erection in
canines.
1998 Jonsson Cancer Center Collaborative Seed Grant Award
1985 UCLA Jonsson Cancer Center Foundation Award
2003 Outstanding Poster. Society of Urologic Oncology Meeting, Baltimore,
MD. "Obesity is an Independent Predictor of Biochemical Failure Following
Radical Prostatectomy”
2004 First Place Poster, Prostate Cancer Therapeutics Section. Western Section
AUA, San Diego, CA. “Growth inhibitory effect of a low-fat diet on prostate
cancer cells in vitro: Results of a prospective randomized dietary intervention
trial in men with prostate cancer.”
|
| Philosophy of Care: |
I believe in honesty and getting to know my patients. I also believe in getting to the point and being direct, while remaining open and listening to other people's ideas. |
Selected Peer Reviewed Publications (from 2004- present):
-
Rajfer J, Aronson WJ, Bush PA, Dorey FJ, and Ignarro LJ: “Nitric Oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission.” New England Journal of Medicine 1992; 326:90.
-
Freedland SJ, Sutter ME, Naitoh J, Dorey F, Csathy G, Aronson WJ.”Clinical Characteristics in black and white men with prostate cancer in an equal access Medical Center. Urology 2000, 55:387-390.
-
Aronson WJ, Glaspy JA, Reddy ST, Reese D, Heber D, Bagga D. "Modulation of Omega-3/Omega-6 Polyunsaturated Ratios with Dietary Fish Oils in Men with Prostate Cancer. Modulation of Omega-3/Omega-6 Polyunsaturated Ratios with Dietary Fish Oils in Men with Prostate Cancer". Urology. 2001 Aug;58(2):283-8.
-
Ngo TH, Barnard RJ, Leung PS, Cohen P, Aronson WJ. Insulin-Like Growth Factor I (IGF-I) and IGF Binding Protein-1 Modulate Prostate Cancer Cell Growth and Apoptosis: Possible Mediators for the Effects of Diet and Exercise on Cancer Cell Survival. Endocrinology. 2003 Jun;144(6):2319-24.
-
Tung HN, Barnard J, Cohen P, Freedland S, Tran C, deGregorio F, Elshimali YI, Heber D, Aronson WJ. Effect of Isocaloric Low-Fat Diet on Human LAPC-4 Prostate Cancer Xenografts in SCID Mice and the IGF Axis. Clinical Cancer Research. 2003 Jul;9(7):2734-43.
-
Freedland SJ, Aronson WJ, Kane CJ, Presti JC Jr, Amling CL, Elashoff D, and Terris MK. Impact of obesity on biochemical control following radical prostatectomy for clinically localized prostate cancer. Journal of Clinical Oncology, 2003 Dec 22.
-
Tung H. Ngo, R. James Barnard, Todd Anton, Chris Tran, David Elashoff, David Heber, and William J. Aronson. Effect of Low-Fat Diet on Androgen-Independent Prostate Tumor Progression and Survival in Mice. Cancer Research. 2004 Feb 15;64(4):1252-4.
-
Okotie OT, Aronson WJ, Wieder JA, Liao Y, Dorey F, DeKernion JB, Freedland SJ. Predictors of metastatic disease in men with biochemical failure following radical prostatectomy. J Urol. 2004 Jun;171(6, Part 1 Of 2):2260-2264.
-
Sonn GA, Aronson W, Litwin MS. Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis. 2005;8(4):304-10. Review.
-
Barnard RJ, Aronson WJ. Preclinical models relevant to diet, exercise, and cancer risk. Recent Results Cancer Res. 2005;166:47-61.
-
Freedland SJ, Isaacs WB, Platz EA, Terris MK, Aronson WJ, Amling CL, Presti JC Jr, Kane CJ. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol. 2005 Oct 20;23(30):7546-54.
-
Henning SM, Aronson W, Niu Y, Conde F, Lee NH, Seeram NP, Lee RP, Lu J, Harris DM, Moro A, Hong J, Pak-Shan L, Barnard RJ, Ziaee HG, Csathy G, Go VL, Wang H, Heber D. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr. 2006 Jul;136(7):1839-43.
-
Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A. A. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res. 2006 Jul 1;12(13):4018-26.
-
Kobayashi N, Barnard RJ, Henning SM, Elashoff D, Reddy ST, Cohen P, Leung P, Hong-Gonzalez J, Freedland SJ, Said J, Gui D, Seeram NP, Popoviciu LM, Bagga D, Heber D, Glaspy JA, Aronson WJ. Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res. 2006 Aug 1;12(15):4662-70.
|
 |